News
economy
iVascular buys 10% shares in US heart valve group
The Catalan biotech group iVascular has acquired 10% of shares in the US group, NaviGate Cardiac Structures Inc., which is based in Lake Forest (California), and specialises in developing heart valves. For the CEO of iVascular, Lluís Duocastella, the acquisition, for €8.67 million, will allow both firms to cooperate in developing heart valves for treating coronary and structural heart disease.
Leave a comment
Sign in.
Sign in if you are already a verified reader.
I want to become verified reader.
To leave comments on the website you must be a verified reader.
Note: To leave comments on the website you must be a verified reader and accept the conditions of use.